The use of <scp>SGLT2</scp> inhibitors in people with diabetes‐related foot disease: A Delphi‐based consensus study
These findings evidence the relative confidence of experienced clinicians in prescribing SGLT2 inhibitors to those with DFD, provided that they do not have a current ulcer and that canagliflozin is not prescribed.
Authors
- Jonathan Valabhji
- Rachel Evley (ORCID: https://orcid.org/0000-0003-4454-5523)
- Solomon Tesfaye (ORCID: https://orcid.org/0000-0003-1190-1472)
- Clare Hambling (ORCID: https://orcid.org/0000-0001-5851-6307)
- Samuel Seidu (ORCID: https://orcid.org/0000-0002-8335-7018)
- Patrick Highton (ORCID: https://orcid.org/0000-0002-0410-5788)
- Frances L. Game (ORCID: https://orcid.org/0000-0002-5294-4789)
- David R. Webb (ORCID: https://orcid.org/0000-0002-3932-3339)
- John R. Petrie (ORCID: https://orcid.org/0000-0002-4894-9819)
- Ketan Dhatariya (ORCID: https://orcid.org/0000-0003-3619-9579)
- Kamlesh K. Khunti (ORCID: https://orcid.org/0000-0003-2343-7099)
- Melanie Jane Davies (ORCID: https://orcid.org/0000-0002-9987-9371)
- Ruksar Abdala (ORCID: https://orcid.org/0009-0007-1164-2155)
- Victoria G. Balasubramanian
Institutions
- University of East Anglia (GB)
- University of Leicester (GB)
- Norfolk and Norwich University Hospitals NHS Foundation Trust (GB)
- Leicester General Hospital (GB)
- National Institute for Health and Care Research (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- Queen Elizabeth Hospital King's Lynn NHS Foundation Trust (GB)
- Chelsea and Westminster Hospital (GB)
- University Hospitals of Derby and Burton NHS Foundation Trust (GB)
- NIHR Leicester Biomedical Research Centre (GB)
- NHS England
- Imperial College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1111/dom.16498
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- National Institute for Health and Care Research
- Diabetes UK